Stay updated on Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Sign up to get notified when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.

Latest updates to the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page now lists Revision: v3.5.4, replacing the previous v3.5.3. This indicates a backend software update and does not alter study records or user-visible content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedThe study record was updated to reflect that results have been posted, adding result content for outcome measures and adverse events alongside the current study status. A prior results submission/revision entry was removed, aligning the history with the newer posted-results version.SummaryDifference0.7%

- Check45 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.1%

- Check66 days agoChange DetectedCore study content sections were added to the record, including Study Description, Study Status, Arms and Interventions, Outcome Measures, Baseline Characteristics, Participant Flow, Adverse Events, References, and Document Section. The update also notes a Returned date (2026-03-19) and that Quality Control Review Has Not Concluded.SummaryDifference1%

- Check73 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the study record history.SummaryDifference0.1%

- Check80 days agoChange DetectedThe record history now includes a new revision entry v3.4.3 and removes the v3.4.2 entry.SummaryDifference0.1%

Stay in the know with updates to Olezarsen in Hypertriglyceridemia and CVD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olezarsen in Hypertriglyceridemia and CVD Clinical Trial page.